The discussions focused on strengthening Hyderabad as a key hub for pharmaceutical production, leveraging the city’s existing infrastructure and industry ecosystem. Chief Minister Revanth assured the company of full government support in facilitating approvals, infrastructure, and operational requirements.

During the meeting, it was highlighted that Hyderabad is home to several major pharmaceutical firms and currently produces around 40% of the country’s bulk drugs, making it an ideal location for expansion. The proposed project is expected to generate significant employment opportunities and further consolidate Hyderabad’s position as a leading center for pharma manufacturing in India.

The post US Pharma Giant Eli Lilly Discusses ₹9,000 Crore Investment in Hyderabad appeared first on India Podcast.